Airway diseases
Interstitial lung diseases
Thoracic oncology
Oral presentation
Novelties in interventional pulmonology
Aims : This session is built from abstracts published on the ERS Congress platform from 23 August, in a PowerPoint format with a pre-recorded audio narration. The live session is scheduled from September 5-7 and each presenter will have a 5-minutes live, slide show presentation followed at the end of the session by 30-minutes general discussion.
Methods :
General respiratory patient care, Endoscopy and interventional pulmonology, Imaging
11:15
Introduction
1
OA229
11:20
Late Breaking Abstract - Bronchoscopic microwave ablation of peripheral lung tumors
K. Lau(London, United Kingdom)
COI
2
11:25
Optical coherence tomography detected changes in airway remodeling after bronchial thermoplasty in severe asthma
P. Wijsman(Amsterdam, Netherlands)
COI
3
11:30
Late Breaking Abstract - Needle based confocal laser endomicroscopy for the diagnosis of peripheral lung nodules by robotic navigational bronchoscopy
C. Manley(Philadelphia, United States)
COI
4
11:35
Histological confidence of transbronchial cryobiopsy in interstitial lung diseases is influenced by sample size
J. Hetzel(Tuebingen, Germany)
COI
5
11:40
In vivo PS-OCT to detect fibrotic lung disease
K. Kalverda(Amsterdam, Netherlands)
COI
6
11:45
Day case rapid pleurodesis in malignant pleural effusion
C. Foo(Victoria, Australia)
COI
7
11:50
Safety of EUS-B-FNA in patients with respiratory insufficiency
U. Bodtger(Naestved, Denmark)
COI
8
11:55
STENTING VERSUS BALLOOON DILATATION IN PATIENTS WITH TRACHEAL BENIGN STENOSIS – THE STROBE TRIAL
D. Andrisani(Modena (MO), Italy)
COI
9
12:00
Efficacy and safety of position selection combined with intra-pleural thrombin injection in the treatment of postoperative persistent air leakage
H. Zhang(Rizhao (Shandong), China)
COI
10
12:05
A multicentre study evaluating bleeding risk with intrapleural enzyme therapy in pleural infection (RETROLYSIS)
E. Bedawi(Sheffield, United Kingdom)
COI
11
12:10
Discussion
12
OA240
. . .
